Guggenheim Reaffirms Their Buy Rating on Pfizer (PFE)
Guggenheim analyst Vamil Divan maintained a Buy rating on Pfizer (PFE – Research Report) yesterday. The company’s shares closed yesterday at ...
When a teeny-weeny rascal halted mankind's mad rush
Pause for a moment. Close your eyes, and rewind to 2020. It was on the evening of 11 March, five years ago, that the Covid-19 ...
Reflecting on the pandemic: Five years since Covid-19 was declared a global crisis
KOCHI: Pause for a moment. Close your eyes, and rewind to 2020. It was on the evening of March 11, five years ago, that the ...
Investing News Network on MSN14h
Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines
Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...
Medscape21h
Data Support Protective Effects of Omicron COVID Vaccine
“The effectiveness of the COVID vaccines can vary depending on which variants are targeted in the vaccine, which variants are circulating, and host factors,” said Shirin A. Mazumder, MD, and ...
Infectious Disease Advisor21h
Updated COVID-19 mRNA-1273.815 Vaccine Effective in Adult Populations
The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.
Hiltzik: A small study of COVID vaccine aftereffects triggers a political and scientific storm
The National Institutes of Health, which falls under the jurisdiction of HHS, has terminated grants for research into vaccine hesitancy, according to the Washington Post, even though the Texas measles ...